Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-07-26

Clinical Trial Update: A Study of Tranexamic Acid (XP12B) in Women With Heavy Menstrual Bleeding [Phase 3]

View source ↗

Summary

A Phase 3 study of tranexamic acid XP12B in women with heavy menstrual bleeding has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tranexamic acid (XP12B) (tranexamic acid)

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Menorrhagia | Phase 3 | Status: COMPLETED | Results posted: 2011-07-26